202 related articles for article (PubMed ID: 9848577)
1. Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study.
Lüftner D; Flath B; Akrivakis C; Mergenthaler HG; Ohnmacht U; Arning M; Possinger K
Invest New Drugs; 1998; 16(2):141-6. PubMed ID: 9848577
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer.
Yardley DA; Peacock NW; Dickson NR; White MB; Vázquez ER; Foust JT; Grapski R; Hendricks LK; Scott WL; Hainsworth JD
Clin Breast Cancer; 2010 Jun; 10(3):217-23. PubMed ID: 20497920
[TBL] [Abstract][Full Text] [Related]
3. Phase I dose escalation study of gemcitabine and paclitaxel plus colony-stimulating factors in previously treated patients with advanced breast and ovarian cancer.
Iaffaioli RV; Tortoriello A; Santangelo M; Turitto G; Libutti M; Benassai G; Frattolillo A; Ciccarelli PD; De Rosa P; Crovella F; Carbone I; Barbarisi A
Clin Oncol (R Coll Radiol); 2000; 12(4):251-5. PubMed ID: 11005695
[TBL] [Abstract][Full Text] [Related]
4. Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I study.
Akrivakis K; Schmid P; Flath B; Schweigert M; Sezer O; Mergenthaler HG; Possinger K
Anticancer Drugs; 1999 Jul; 10(6):525-31. PubMed ID: 10885899
[TBL] [Abstract][Full Text] [Related]
5. A phase I study of gemcitabine and epirubicin for the treatment of platinum-resistant or refractory advanced ovarian cancer.
Pignata S; Varriale E; Casella G; Iodice F; De Placido G; Perrone F; Tramontana F; Ricchi P; De Vivo R; Costanzo R; Vernaglia A; Tramontana S
Ann Oncol; 2000 May; 11(5):613-6. PubMed ID: 10907958
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine combined with epirubicin in the treatment of patients with locally advanced or metastatic breast cancer: a phase II study.
Hausmaninger H; Morack G; Heinrich B; Wallwiener D; Höffken K; Buksmaui S; Krejcy K; Miller MA; Possinger K
Am J Clin Oncol; 2004 Aug; 27(4):429-35. PubMed ID: 15289740
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.
Medioni J; Huchon C; Le Frere-Belda MA; Hofmann H; Bats AS; Eme D; Andrieu JM; Oudard S; Lecuru F; Levy E
Drugs R D; 2011; 11(2):147-57. PubMed ID: 21679005
[TBL] [Abstract][Full Text] [Related]
8. Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial.
Schneeweiss A; Schuetz F; Rudlowski C; Hahn M; Lauschner I; Sinn HP; von Fournier D; Sohn C
Anticancer Drugs; 2005 Oct; 16(9):1023-8. PubMed ID: 16162980
[TBL] [Abstract][Full Text] [Related]
9. Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience.
Catimel G; Spielmann M; Dieras V; Tubiana-Hulin M; Bonneterre J; Pouillart P; Kayitalire L; Guastalla JP; Graffand N; Garet F; Dumortier A; Pellae-Cosset B
Semin Oncol; 1997 Feb; 24(1 Suppl 3):S8-12. PubMed ID: 9071333
[TBL] [Abstract][Full Text] [Related]
10. Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study.
Riccardi A; Brugnatelli S; Danova M; Giordano M; Pugliese P; Luchena G; Grasso D; Trotti G; Bertè R; Pansini G; Tinelli C
Tumori; 2006; 92(1):6-12. PubMed ID: 16683377
[TBL] [Abstract][Full Text] [Related]
11. An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer.
Bonnefoi H; Biganzoli L; Cufer T; Mauriac L; Hamilton A; Schaefer P; Piccart M
Breast Cancer Res Treat; 2001 Nov; 70(1):55-63. PubMed ID: 11768362
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results of an ongoing phase I/II study.
Steward WP; Dunlop DJ; Cameron C; Talbot DC; Kleisbauer JP; Thomas P; Guerin JC; Perol M; Sanson C; Dabouis G
Anticancer Drugs; 1995 Dec; 6 Suppl 6():33-7. PubMed ID: 8718423
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant therapy with gemcitabine in breast cancer.
Schneeweiss A; Bastert G; Huober J; Wallwiener D; Hamerla R; Lichter P
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 12):27-31. PubMed ID: 15685823
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study.
Schneeweiss A; Huober J; Sinn HP; von Fournier D; Rudlowski C; Beldermann F; Krauss K; Solomayer E; Hamerla R; Wallwiener D; Bastert G
Eur J Cancer; 2004 Nov; 40(16):2432-8. PubMed ID: 15519516
[TBL] [Abstract][Full Text] [Related]
15. The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancer.
Conte P; Salvadori B; Donati S; Gennari A; Cetto GL; Molino A; Crino L; Mazzoni F; Galligioni E; Mansutti M
Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):41-3. PubMed ID: 11252889
[TBL] [Abstract][Full Text] [Related]
16. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
[TBL] [Abstract][Full Text] [Related]
17. Advanced breast cancer: investigational role of gemcitabine.
Carmichael J; Walling J
Eur J Cancer; 1997 Jan; 33 Suppl 1():S27-30. PubMed ID: 9166097
[TBL] [Abstract][Full Text] [Related]
18. Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer.
Venturini M; Del Mastro L; Garrone O; Angiolini C; Merlano M; Bergaglio M; Tolino G; Lambiase A; Baldini A; Canavese G; Rosso R
Ann Oncol; 2002 Apr; 13(4):546-52. PubMed ID: 12056704
[TBL] [Abstract][Full Text] [Related]
19. The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancer.
Gennari A; Donati S; Danesi R; Fogli S; Orlandini C; Del Tacca M; Conte PF
Semin Oncol; 2000 Feb; 27(1 Suppl 2):14-9. PubMed ID: 10697031
[TBL] [Abstract][Full Text] [Related]
20. Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.
Hidalgo M; Castellano D; Paz-Ares L; Gravalos C; Diaz-Puente M; Hitt R; Alonso S; Cortes-Funes H
J Clin Oncol; 1999 Feb; 17(2):585-92. PubMed ID: 10080603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
